Investors knock $1b off F&P Healthcare valuation

Investors knock $1b off F&P Healthcare valuation
Dan Brunskill
New Zealand's main share index slumped as investors reacted poorly to Fisher & Paykel Healthcare’s full-year result which failed to meet the high expectations priced into the stock. The S&P/NZX 50 Index fell 104.1 points, or 0.8%, to 12,243.34. Within the index, 27 stocks fell, 16 rose and 7 were unchanged. The index has fallen more than 8% this year. F&P Healthcare has been doing extraordinarily well during the pandemic as the exporter supplies hospitals around the world with equipment needed to treat covid-19.T...

More Markets

Salt throws its support behind Marsden Maritime Holdings takeover
Markets

Salt throws its support behind Marsden Maritime Holdings takeover

The institutional shareholder owns 3.49% of the land-owning company.

ANZ half-year profit surges on non-cash gains
Finance

ANZ half-year profit surges on non-cash gains

Cash earnings were flat, and net interest margin rose slightly.

Neuren's 'embarrassment of opportunities'
Markets

Neuren's 'embarrassment of opportunities'

The pharmaceutical firm is pushing for approval of multiple phase-three trials in 2026.